Mammographic density to predict response to neoadjuvant systemic breast cancer therapy

被引：0

作者：

S. Di Cosimo

C. Depretto

R. Miceli

P. Baili

S. Ljevar

M. Sant

V. Cappelletti

S. Folli

M. Gennaro

F. G. De Braud

G. Bianchi

A. Vingiani

G. Pruneri

A. Marchianò

E. La Rocca

M. C. De Santis

G. P. Scaperrotta

机构：

[1] Fondazione IRCCS Istituto Nazionale Dei Tumori,Biomarkers Unit, Department of Applied Research and Technological Development

[2] Istituto Nazionale Tumori,Radiology Unit, Fondazione IRCCS

[3] Fondazione IRCCS Istituto Nazionale Tumori,Department of Clinical Epidemiology and Trial Organisation

[4] Fondazione IRCCS Istituto Nazionale Dei Tumori,Analytical Epidemiology and Health Impact Unit

[5] Fondazione IRCCS Istituto Nazionale Dei Tumori,Breast Surgery Unit

[6] Fondazione IRCCS Istituto Nazionale Dei Tumori,Division of Medical Oncology 1

[7] Fondazione IRCCS Istituto Nazionale Dei Tumori,Department of Pathology

[8] Fondazione IRCCS Istituto Nazionale Dei Tumori,Radiation Oncology 1

来源：

Journal of Cancer Research and Clinical Oncology | 2022年 / 148卷

关键词：

Breast cancer; Mammographic density; Medical subject headings (MeSH); Neoadjuvant therapy; Pathological complete response;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

下载

页码：775 / 781

页数：6

共 50 条

[21] Hormone therapy, mammographic density, and breast cancer risk
Martin, Lisa J.
Minkin, Salomon
Boyd, Norman F.
MATURITAS, 2009, 64 (01) : 20 - 26
[22] ACCURACY OF ULTRASOUND DURING NEOADJUVANT THERAPY FOR BREAST CANCER TO PREDICT PATHOLOGIC RESPONSE
Marinovich, Michael Luke
Houssami, Nehmat
Macaskill, Petra
Von Minckwitz, Gunter
Blohmer, Jens U.
Irwig, Les
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 37 - 37
[23] Mammographic Density, Response to Hormones, and Breast Cancer Risk
Boyd, Norman F.
Melnichouk, Olga
Martin, Lisa J.
Hislop, Greg
Chiarelli, Anna M.
Yaffe, Martin J.
Minkin, Salomon
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (22) : 2985 - 2992
[24] Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy
Fujii, Takeo
Kogawa, Takahiro
Wu, Jimin
Sahin, Aysegul A.
Liu, Dian D.
Chavez-MacGregor, Mariana
Giordano, Sharon H.
Raghavendra, Akshara
Murthy, Rushmy K.
Tripathy, Debu
Shen, Yu
Yamal, Jose-Miguel
Ueno, Naoto T.
BRITISH JOURNAL OF CANCER, 2017, 116 (04) : 509 - 514
[25] Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy
Takeo Fujii
Takahiro Kogawa
Jimin Wu
Aysegul A Sahin
Dian D Liu
Mariana Chavez-MacGregor
Sharon H Giordano
Akshara Raghavendra
Rushmy K Murthy
Debu Tripathy
Yu Shen
Jose-Miguel Yamal
Naoto T Ueno
British Journal of Cancer, 2017, 116 : 509 - 514
[26] Predictors of complete pathological response after neoadjuvant systemic therapy for breast cancer
Tan, Marcus C.
Al Mushawah, Fatema
Gao, Feng
Aft, Rebecca L.
Gillanders, William E.
Eberlein, Timothy J.
Margenthaler, Julie A.
AMERICAN JOURNAL OF SURGERY, 2009, 198 (04): : 520 - 525
[27] The Role of Mammographic Calcification in the Neoadjuvant Therapy of Breast Cancer Imaging Evaluation
Li, Jun-jie
Chen, Canming
Gu, Yajia
Di, Genhong
Wu, Jiong
Liu, Guangyu
Shao, ZhiMin
PLOS ONE, 2014, 9 (02):
[28] Breast Cancer Screening with mammographic breast density Combination breast cancer risk and mammographic breast density can predict risk for invasive breast cancer within a year after mammography
Haugen, Trine B.
TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2015, 135 (14) : 1245 - 1245
[29] Breast Mammographic Density: Stromal Implications on Breast Cancer Detection and Therapy
Fernandez-Nogueira, Patricia
Mancino, Mario
Fuster, Gemma
Bragado, Paloma
Prats de Puig, Miquel
Gascon, Pere
Javier Casado, Francisco
Carbo, Neus
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (03)
[30] Omission of breast surgery in selected breast cancer patients with excellent response to neoadjuvant systemic therapy
Tasoulis, Marios-Konstantinos
Muktar, Samantha
Smith, Ian
Roche, Nicola
Macneill, Fiona
EJSO, 2024, 50 (06):

← 1 2 3 4 5 →